İş dünyası · 20.05.20241 dk okuma
Prospective Grant of an Exclusive Patent License: T Cell Receptor Fusion Proteins for the Treatment of Cancer
Yerel otomatik çeviri · Kaynağın orijinal dili
Özet
The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the Patents and Patent Applications listed in the Supplementary Information section of this notice to INTcRON LLC ("INTcRON") located in Memphis, Tennessee.